Grant: CIHR Fellowship
Direct Payment
$150,000.00
Improving Measurements of Intracellular Signaling in Leukemia - A Basis for Diagnosis and Treatment
EF 2008-09
Résumé
Abnormalities in cell signaling mechanisms (e.g., protein phosphorylation/dephosphorylation) drive tumour expansion and suppress cell death, contributing to tumour survival despite intense therapeutic regimens. Recent studies by our group, using flow cytometry to monitor these events in leukemia and lymphoma isolates, have been able to correlate phospho-protein status mechanistically with clinical outcome. However using conventional flow cytometry, measurement of more than 6 parameters simultaneously to obtain this "biosignature" for each sample becomes prohibitively challenging. Therefore this analysis provides a quantitative but limited view of what we know to be the intricacy of complex transformation in heterogeneous cell populations in vivo. Yet, a recent breakthrough in flow cytometry technology has significantly expanded the number of parameters that can be simultaneously measured in a single experiment (theoretically more than 100). With this, our goal is to apply simple modifications to protocols already established in our lab for quantization of cellular signaling events to significantly improve the phospho-protein biosignature of leukemia and thus its diagnosis and treatment. Using this, we will test the hypothesis that both tumour heterogeneity and clinical outcomes can be correlated to the level of signaling heterogeneity (on a cell by cell level), and the significance of this correlation can be vastly increased as we profile more deeply those signaling networks that drive tumour growth and development.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
173995
Name
Bendall Sean C
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Improving Measurements of Intracellular Signaling in Leukemia - A Basis for Diagnosis and Treatment
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bayesian Network; Biomarker; Cancer; Cell Signalling; Chemotherapy; Flow Cytometry; Leukemia; Phosphorylation; Proteomics; Single Cell
Abstract
Abnormalities in cell signaling mechanisms (e.g., protein phosphorylation/dephosphorylation) drive tumour expansion and suppress cell death, contributing to tumour survival despite intense therapeutic regimens. Recent studies by our group, using flow cytometry to monitor these events in leukemia and lymphoma isolates, have been able to correlate phospho-protein status mechanistically with clinical outcome. However using conventional flow cytometry, measurement of more than 6 parameters simultaneously to obtain this "biosignature" for each sample becomes prohibitively challenging. Therefore this analysis provides a quantitative but limited view of what we know to be the intricacy of complex transformation in heterogeneous cell populations in vivo. Yet, a recent breakthrough in flow cytometry technology has significantly expanded the number of parameters that can be simultaneously measured in a single experiment (theoretically more than 100). With this, our goal is to apply simple modifications to protocols already established in our lab for quantization of cellular signaling events to significantly improve the phospho-protein biosignature of leukemia and thus its diagnosis and treatment. Using this, we will test the hypothesis that both tumour heterogeneity and clinical outcomes can be correlated to the level of signaling heterogeneity (on a cell by cell level), and the significance of this correlation can be vastly increased as we profile more deeply those signaling networks that drive tumour growth and development.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bendall, Sean C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~